NYU Langone Hospital Receives $250K from Cutting-Edge Alzheimer’s Disease Research
NYU’s Langone Hospital—Long Island just received a $250,000 grant from the Alzheimer’s Foundation of America (AFA) to expand and accelerate […]
NYU’s Langone Hospital—Long Island just received a $250,000 grant from the Alzheimer’s Foundation of America (AFA) to expand and accelerate […]
Eli Lilly and Co inked a deal to gain worldwide, exclusive licensing rights to the autoimmune and inflammatory disease treatment […]
With a growing array of smart applications, ubiquitous cloud compute infrastructure and Big Data, new forms of remote clinical research […]
Ireland-domiciled Jazz Pharmaceutical is apparently sold as the first developer of what is the first and only U.S. Food and […]
An Interview with Dr. Ian Smith, Founder, Director and Chief Medical Officer of Panthera Biopartners and CEO of Panthera […]
The National Institute of Aging (NIA), part of the National Institutes of health (NIH) and the Alzheimer’s Drug Discovery Foundation […]
Although much attention has focused on the opioid epidemic, a parallel methamphetamine crisis rages on while the COVID-19 pandemic continues […]
Patients with Parkinson’s disease who are treated with deep brain stimulation (DBS) generally have unpredictable and varied speech outcomes after […]
Biogen recently announced a new digitally-powered virtual study in partnership with Apple to identify digital biomarkers to help monitor cognitive […]
The School of Medicine at the University of California, Riverside (UC Riverside) will serve as lead investigational site for a […]